Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE)
Solicitation from NATIONAL INSTITUTES OF HEALTH • HEALTH AND HUMAN SERVICES, DEPARTMENT OF. Place of performance: DC. Response deadline: Feb 05, 2026. Industry: NAICS 541714 • PSC AN13.
Market snapshot
Baseline awarded-market signal across all contracting (sample of 400 recent awards; refreshed periodically).
Related hubs & trends
Navigate the lattice: hubs for browsing, trends for pricing signals.
Point of Contact
Agency & Office
More in NAICS 541714
Description
https://api.sam.gov/prod/opportunities/v1/noticedesc?noticeid=e2dfbdba502742c480b847d537e78e72
Files
Files size/type shown when available.
BidPulsar Analysis
A practical, capture-style breakdown of fit, requirements, risks, and next steps.
The THRIVE program under ARPA-H is focused on the treatment of hereditary rare diseases using in vivo precision genetic medicines. It seeks innovative solutions through research and development and aims to leverage advanced genetic technologies for effective therapeutic strategies. This initiative represents a unique funding opportunity for organizations specializing in genetic medicine, biotechnology, and rare diseases.
The buyer is aiming to solicit proposals that develop precision genetic medicines targeting hereditary rare diseases. The objective is to advance scientific understanding and applications of genetic therapies that can transform patient outcomes.
- Understanding the requirements of in vivo precision genetic medicines
- Developing a comprehensive research proposal
- Demonstrating expertise in hereditary rare diseases
- Creating a solid project plan
- Outlining milestones and deliverables for the proposed solution
- Cover letter
- Business proposal outlining approach and team expertise
- Research plan with timelines
- Budget outline and funding justification
- Compliance documentation related to genetic research
Source coverage notes
Some notices publish limited source detail. Confirm these points before final bid/no-bid decisions.
- Specific requirements or guidelines for proposal format
- Evaluation criteria used by the selection committee
- Detailed timeline for proposal review and selection process
- Budget cap or funding limits for proposals
- Expected range of project duration before outcomes are realized
FAQ
How do I use the Market Snapshot?
It summarizes awarded-contract behavior for the opportunity’s NAICS and sector, including a recent pricing band (P10–P90), momentum, and composition. Use it as context, not a guarantee.
Is the data live?
The signal updates as new awarded notices enter the system. Always validate the official award and solicitation details on SAM.gov.
What do P10 and P90 mean?
P10 is the 10th percentile award size and P90 is the 90th percentile. Together they describe the typical spread of award values.